Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,590 | 2,880 | 4,160 | 1,010 | 1,690 |
| Marketable Securities | 1,270 | 1,270 | 0 | 1,050 | 1,050 |
| Receivables | 680 | 590 | 970 | 260 | 260 |
| Inventories | 200 | 300 | 400 | 260 | 320 |
| Other current assets | 50 | 40 | 10 | 20 | 10 |
| TOTAL | $4,790 | $5,080 | $5,540 | $2,600 | $3,330 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 1,960 | 2,200 |
| Other Non-Current Assets | 2,880 | 2,860 | 4,660 | 4,740 | 4,810 |
| TOTAL | $2,880 | $2,860 | $4,660 | $6,700 | $7,010 |
| Total Assets | $7,740 | $8,010 | $10,280 | $9,380 | $10,420 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 370 | 610 | 660 | 660 | 800 |
| Other current liabilities | 920 | 600 | 620 | 700 | 770 |
| TOTAL | $1,300 | $1,210 | $1,280 | $1,360 | $1,580 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $10 | $10 | $10 | $10 | $10 |
| Total Liabilities | $1,310 | $1,230 | $1,300 | $1,380 | $1,590 |
| Shareholders' Equity | |||||
| Common Shares | 6,090 | 6,090 | 6,090 | 6,000 | 5,990 |
| Retained earnings | -146,620 | -146,070 | -144,770 | -144,930 | -144,140 |
| Other shareholders' equity | 790 | 440 | 1,320 | 1,440 | 1,490 |
| TOTAL | $6,420 | $6,780 | $8,980 | $7,990 | $8,820 |
| Total Liabilities And Equity | $7,730 | $8,010 | $10,280 | $9,370 | $10,410 |